Clonal eosinophilic disorders and the hypereosinophilic syndrome

Blood Reviews

Volumn 11, Issue 3, 1997, Pages 129-145

  Brito Babapulle, F ^a  

^a ROYAL BERKSHIRE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; BLOOD CELL COUNT; CELL CLONE; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC LEUKEMIA; HUMAN; HYPEREOSINOPHILIC SYNDROME; LYMPHATIC LEUKEMIA; MASTOCYTOSIS; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVIEW;

EID: 12644276390     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(97)90008-4     Document Type: Article

References (234)

1. Yamagushi Y, Suda T, Ohta S et al. Analysis of the survival of mature human eosinophils; interleukin 5. Blood 1991; 78: 1542.
2. Spry CJF. The natural history of eosinophils. In Smith H, Cook R, eds. The Immunopharmacology of Eosinophils. London: Academic Press, 1993: 1.
3. Durham S R. Kay A B. Eosinophils, bronchial hyper reactivity and late-phase asthmatic reactions. Clin Allergy 1985; 15: 411.
4. Limaye A P. Abrams J S, Silver J E, Ottesen E A, Nutman T B. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients J Exp Med 1990; 172: 399.
5. Nuzum J W Jr, Nuzum J W. Polyarteritis nodosa: statistical review on 175 cases from the literature and report on a typical case. Arch Intern Med 1954; 94: 942.
6. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951; 27: 277.
7. Lowe D, Jorrizzo H, Hutt M S R. Tumour associated eosinophilia: a review. J Clin Pathol 1981; 34: 1343.
8. Stillman R G. A case of myeloid leukaemia with predominance of eosinophilic cells. Med Rec 1912; 81: 594.
9. Boveri T. Zur Frage der Entstehung maligner Tumoren. Jena: Gustav Fischer, 1914.
10. Hardy W R, Anderson R E. The hypereosinophilic syndromes. Ann Intern Med 1968; 68: 1220.
11. Benvenisti D S, Ultman J E. Eosinophilic leukaemia, report of 5 cases and review of the literature. Ann Int Med 1969 71: 731.
12. Chusid M J, Dale D C, West B C, Wolff S N. The hypereosinophilic syndrome: analysis of 14 cases with review of literature. Medicine (Baltimore) 1975;54: 1.
13. Enokihara H, Furusawa S, Nakakubo H. T cells from eosinophilic patients produce interleukin 5 with interleukin 2 stimulation. Blood 1989; 3: 1809.
14. Weller P F, Goetzl E J. The regulatory and effector roles of eosinophils. Adv Immuno 1979; 27: 339.
15. γ+ IL2+) in classical delayed-type hypersensivity reactions in human skin. J Immunol 1992; 148: 2058.
16. Hamid Q, Azzawi M, Sun Ying et al. Expression of mRNA for IL5 in mucosal bronchial biopsies from asthmatic subjects. J Clin Invest 1991; 87: 1541.
17. Wong D T, Weller P F, Galli S J et al. Human eosinophils express transforming growth factor α. J Exp Med 1990; 172: 673.
18. Kay A B, Sun Ying, Varney V. Messenger mRNA expression of the cytokine gene cluster IL3, IL4, IL5 and GM-CSF in allergen-induced late phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775.
19. Fuggle W J, Crocker J, Smith P J. A quantitative study of eosinophil polymorphs in Hodgkin's disease. J Clin Pathol 1984; 37: 267.
20. Bailey C C, Campbell R H. Lymphosarcoma presenting as Loeffler's syndrome. Br Med J 1973; 1: 460.
21. Shepherd N A, Blackshaw A J, Hall P A et al. Malignant lymphoma with eosinophilia of the gastrointestinal tract. Histopathology 1987; 11: 115.
22. Gardais J, Fanello S E, Joubaud F, Simard C. Leukaemoid eosinophilic reaction in angioimmunoblastic lymphadenopathy. Rev Med Interne 1984; 5: 309.
23. Whittaker S J, Russell-Jones R, Spry C J. Lymphomatoid papulosis and its relationships to 'idiopathic hypereosinophilic syndrome'. J Am Acad Dermatol 1988; 18: 339.
24. Gelfand E W, McCurdy D, Rao C P, Cohen A. Absence of lymphocyte ecto-5′-nucleotidase in infants with reticuloendotheliosis and eosinophilia (Omenn's Syndrome). Blood 1984; 63: 1475.
25. Kuo T T, Hsueh S, Su I J, Gonzalez Crussi F, Chen J S. Histiocytoid haemangoima of the heart with peripheral eosinophilia. Cancer 1985; 55: 2854.
26. Kimura T, Yoshima S, Ishikawa E. Unusual granulation combined with hyperplastic change of lymphoid tissue. Trans Jpn Path Soc 1948; 37: 179.
27. Kung I T, Gibson J B, Bannatyne P M. Kimura's disease: a clinicopathological study of 21 cases and its distinction from angiolymphoid hyperplasia with eosinophilia. Pathology 1984; 16: 39.
28. Youn I L. The eosinophil and gastrointestinal carcinoma. Am J Surg 1959; 97: 195.
29. Ounby H E, Roi L D, Isenberg R R, Brennan M J. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer 1983; 52: 126.
30. Bauke J, Rottger P. Hochgradige eosinophil Reaktion bei Hypernephrom. Med Welt 1966; 16: 865.
31. Sala A M, Stein R J. A case of carcinoma of the cervix with a blood picture simulating chronic aleukaemic eosinophilic leukaemia. Am J Cancer 1937; 29: 125.
32. Yang L C, Lee M S, Tsai C L, Chang C C, Lin Y N, Hsu C T. Uterine cervical cancer associated with eosinophilic infiltration. Asia Oceania J Obstet Gynaecol 1984; 10: 105.
33. Knox A J, Johnson C E, Page R L. Eosinophilia associated with thoracic malignancy. Br J Dis Chest 1986; 80: 92.
34. Kern P, Horstmann R D. Dietrich M. Eosinophil production in normal bone marrow cultures induced by 80-85 kDa serum components of patients with eosinophilia. Br J Haematol 1987;66: 165.
35. Sanderson C J. Interleukin 5, eosinophils and disease. Blood 1992; 79: 3101.
36. Case records of the Massachusetts General Hospital. Weekly Clinico pathological exercise Case 30. A 74 year old man with azotemia, eosinophilia and peripheral cyanosis and mottling. N Eng J Med 1986; 315: 308.
37. Piraino B M, Silver M R, Dominiquez J H, Puschett J B. Peritoneal eosinophils during intermittent peritoneal dialysis. Am J Nephrol 1984; 4: 152.
38. Backenroth R, Spinowitz B S, Galler M, Golden R A. Rascoff J H. Charytan C. Comparison of eosinophilia in patients undergoing peritoneal dialysis and haemodialysis. Am J Kidney Dis 1986; 8: 186.
39. Durieu I, Nove Josserand R, Cathebras P et al. Eosinophilic ascites: 2 new case reports. Rev Med Interne 1992; 13: 446.
40. Vandewiele I A, Maeyaert C M, Can Cutsem E J, Geboes K R. Knockaert D C. Massive eosinophilic ascites: differential diagnosis between idiopathic hypereosinophilic syndrome and eosinophilic gastroenteritis. Acta Clin Belg 1991; 46: 37.
41. Shalev O, Rubinger D, Barlatzky Y, Kopolovic J, Drukker A. Eosinophilia associated with acute allograft, kidney rejection. Nephron 1982; 31: 182.
42. Virmani R, Chun P K, Dunn B E, Hartmen D, McAllister H A. Eosinophilic constrictive pericarditis. Am Heart J 1984; 107:803.
43. Spry C J, Eosinophils in eosinophilic endomyocardial disease. Postgrad M J 1986;62:609.
44. Donhuijsen K, Haedicke C, Hattenberger S, Hauswaldt C, Freund M. Granulocyte-macrophage colony-stimulating factor-related eosinophilia and Loeffler's endocarditis. Blood 1992; 79: 2798 (letter).
45. Felice P V, Sawicki J, Anto J. Endomyocardial disease and eosinophilia. Angiology 1993; 44: 869.
46. Davies J N. Endocardial fibrosis in Africans. East Afr Med J 1948; 25: 10.
47. Chew C Y, Ziady G M, Raphael M J, Nellen M, Oakley C M. Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease Br Heart J 1977; 39: 399.
48. Taliercio C P, Olney B A, Lie J T. Myocarditis related to drug hypersensitivity. Mayo Clinic Proc 1985;60: 463.
49. Salzman M B, Valderrama E. Sood S K. Carbamezepine and fatal eosinophilic myocarditis. N Eng J Med 1977; 336: 878.
50. Gleich G J, Schroeter A L, Marcoux J P, Sachs M I, O'Connell E J, Kohler P F. Episodic angioedema associated with eosinophilia. N Eng J Med 1984; 310: 1621.
51. Culpepper R C, Williams R G, Mease P J, Koepsell T D, Kobayashi J M. Natural history of the eosinophilia myalgia syndrome. Ann Intern Med 1991; 115: 437.
52. Rosengberg S A, Lotze M T, Muul L M. Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant IL2 to patients with metastatic cancer. N Eng J Med 1985; 313: 1485.
53. Marti G E, Chiang J L, Patterson R. The syndrome of hyper IgM eosinophilia. edema and fatigue: immunologic studies and long term evaluation of two patients. Int Arch Allergy Appl Immunol 1980;63: 83.
54. Rigau Perez J E. Perez Alvarez L, Duenas Castro S et al. Epidemiological investigation of an oil associated pneumonia paralytic eosinophilic syndrome in Spain. Am J Epidemiol 1984; 119: 250.
55. Wattiaux M J, Khalife J, Prin L et al. Syndrome hypereosinophilique chez un sujet HIV 1 +. Rev Med Interne 1989; 10: 249.
56. Carbonell Rabanal M A, Alonso Pacheco M L, Caballero Hemaez P. Rodriquez Zapata M. Sindrome hipereosinofilo en paciente VIH +. Rev Clin Esp 1992; 190: 278.
57. May L P, Kelly J, Sanchez M. Hypereosinophilic syndrome with unusual cutaneous manifestations in two men with HIV infection. J Am Acad Dermatol 1990; 23: 202.
58. Kaplan M H, Hall W W, Susin M et al. Syndrome of severe skin disease, eosinophilia and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. Am J Med 1991; 91: 300.
59. Bain B. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome Br J Haem 1996; 96: 2.
60. Ishibashi T, Kimura H, Abe R, Matsuda A, Uehida T, Karoyone S. Involvement of eosinophils in leukaemia: cytogenetic studies of eosinophilic colonies from acute myelogenous leukaemia associated with translocation (8:21). Cancer Genet Cytogenet 1986; 22: 189.
61. Koeffler H P, Levine A M, Sparkes M, Sparkes R S. Chronic myeloid leukaemia: eosinophils involved in the malignant clones. Blood 1980; 55: 1063.
62. Imai Y, Yasuhara S, Hanafusa N et al. Clonal involvement of eosinophils in therapy related myelodysplastic syndrome with eosinophilia, translocation t(1:7) and lung cancer. Br J Haematol 1996; 95: 710.
63. Kimura H, Abe R, Shiga Y et al. A case of acute myelogenous leukaemia associated with eosinophilia: cytogenetic study of eosinophilic colonies showing the origin of the abnormal clones. Acta Haematol (Basel) 1987; 77: 15.
64. Gershwin M E, Fajardo L F, Gurwith M, Kosek J C. Eosinophilia terminating in myeloblastoma. Am J Med 1972; 53: 348.
65. Goh K O, Swisher S N, Rosenberg C A. Cytogenetic studies in eosinophilic leukaemia. Ann Intern Med 1965; 62: 80.
66. Kwong Y L, Chan L C. Involvement of eosinophils in acute myeloid leukaemia with monosomy 7 demonstrated by fluorescence in situ hybridization. Br J Haematol 1994; 88: 389.
67. Goldman J, Najfeld V, Th'ng K H. Agar culture and chromosomal analysis in eosinophilic leukaemia. J Clin Pathol 1975; 28: 956.
68. Luppi M, Marascha R, Morselli M, Barozzi P, Torelli G. Clonal nature of hypereosinophilic syndrome. Blood 1994; 84: 349.
69. Chang H W, Leong K H, Koh D R, Lee S H. Clonal origin of eosinophils in the hypereosinophilic syndrome detected by PCR analysis of DNA polymorphisms of the X linked human androgen receptor gene. Int J Haematol 1996; 64: Suppl 1, 843.
70. da Silva M A, Heerema N, Schuenk G R Jr, Hoffman R. Evidence for the clonal nature of the hypereosinophilic syndrome. Cancer Genet Cytogenet 1988; 32: 109.
71. Lefervre C, Bletry O, Degalut P et al. Facteurs pronostiques due syndrome hypereosinophilique: etude de 40 observations. Ann Med Interne (Paris) 1989; 140: 253.
72. Srivastava A, Boswell H S, Heerema N A et al. Kras oncogene overexpression in myelodysplastic syndrome with translocation 5: 12. Cancer Genet Cytogenet 1988; 51: 277.
73. de Korte D, Haverkort W A, Behrendt H, Roos D, can Gennip A H. Abnormal nucleotide pattern in the eosinophils of a patient with acute lymphoblastic leukaemia associated with eosinophilia. Leuk Res 1986; 10: 1419.
74. + T cells with chromosome 16 anomalies. Br J Haematol 1996; 92: 315.
75. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of Type 2 Helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330:535.
76. Stockdill G, Hartley S E, Allan N C. Eosinophilic leukaemia in association with a double Philadelphia chromosome. Postgrad Med Journal 1980; 56: 268.
77. Brockington I F, Luzzatto L, Osunkoya B O. The heart in eosinophilic leukaemia. Afr J Med Sci 1970; 1: 343.
78. Banka V S, Khattri H N, Dass K C. Cardiac involvement and hypofibrinogenaemia in a case of chronic eosinophilic leukaemia. J Assoc Physician Ind 1971; 19: 319.
79. Wolz D E, Granato J E, Giles H R, Marks S M. Grill H P. A unique chromosomal abnormality in idiopathic hypereosinophilic syndrome presenting with cardiac involvement. Am Heart J 1993; 126: 246.
80. Noguchi H, Kephart G M, Colby T V, Gleich G J. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 1992; 140: 521.
81. Allen J N, Davis W B. What is eosinophilic pneumonia? Arch Intern Med 1992; 152: 1765 (editorial).
82. Bass D A, Grover W H, Lewis J C et al. Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest 1980; 66: 1265.
83. Caulfield J P, Hein A, Rothenburg M E et al. A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro. Am J Pathol 1991; 137: 21.
84. Winqvist I, Oloffson T, Olsson I, Persson A M, Hallberg T. Altered density metabolism and surface receptors of eosinophils in eosinophilia. Immunology 1982; 47: 531.
85. Winqvist I, Olofsson T, Olsson I. Mechanisms for eosinophil degranulation: release of the eosinophil cationic protein. Immunology 1984; 51: 1.
86. Ezekwesili R, Brito-Babapulle F. Clonal haemopoiesis accounts for 0.9% of moderate to severe eosinophilia. Br J Haematol 1997; 97: 69(suppl 1).
87. Rani S, Gautam P, Prakash S, Singh T. Ring eosinophils in hypereosinophilic syndrome Br J Haematol 1992;87: 132.
88. Hernandez P, Cavrera H, Espinosa E, Gonzales A, Palacios N. Ring eosinophils in human haematological malignancies. Br J Haematol 1989; 72: 597.
89. Bain B J. The significance of ring eosinophils in humans. Br J Haematol 1989; 73: 580-581 (letter).
90. Spry C J F. The idiopathic hypereosinophilic syndrome (HES). In: investigations in eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature. Oxford: Oxford Medical Publications, 1988; ch 25, p. 278.
91. Chusid M J, Dale D C. Eosinophilic leukaemia. Am J Med 1975; 59: 297.
92. Androuny A, Seraydarian A, Levine A M et al. Cyclic eosinophilic leucocytosis in eosinophilic leukaemia with observations on transcobalamin I and eosinophils. Cancer 1984; 54: 1374.
93. Yoo T J, Orman S V, Patil S R et al. Evolution to eosinophilic leukaemia with t(5:11) translocation in a patient with idiopathic HES. Cancer Genet Cytogenet 1984; 11: 389.
94. Sato H, Danbara M, Tamura M, Morita M. Eosinophilic leukaemia with a t(2:5) (p23;q35) translocation. Br J Haem 1994; 87: 404.
95. MacDougall L, Falkson G, Ruff P, Bernstein R. Abnormalities of chromosome 12p13 and malignant proliferation of eosinophils: a non random association. Br J Haematol 1987; 67: 25.
96. Jani K, Kempski H M, Reeves B R. A case of myelodysplasia with eosinophilia having a translocation t(5:12)(q31;q13). Br J Haematol 1994; 87: 57.
97. Gotic M, Radosevic-Radojkovic N, Ludoski M et al. Eosinophilic leukaemia with chromosomal aberration t(5:12)q(31;q13). Br J Haematol 1994; 87:Suppl 1: 68.
98. Ross F M, Hamilton M, Cook M K, Irving J B. A myelodysplastic syndrome with eosinophilia associated with a break in the short arm of chromosome 16. Leukaemia 1987; 1: 680.
99. Hild F, Fontasch C. Cytogenetic peculiarities in chronic myelogenous leukaemia. Cancer Genet Cytogenet 1990; 47: 197.
100. Viniou N, Yataganas X, Abazis D et al. Hypereosinophilia associated with monosomy 7. Cancer Genet Cytogenet 1995; 80: 68.
101. Yamaoka K A, Kolb J P. Eosinophilic leukaemia with a t(2;5)(p23q35) translocation. Br J Haematol 1994; 87: 406.
102. Bitran J D, Rowley J D, Plapp F, Golomb H M, Ultman J E. Chromosomal aneuploidy in a patient with hypereosinophilic syndrome: evidence for a malignant disease. Am J Med 1977; 68: 101.
103. Cabrol C. Chromosomal anomaly in eosinophilic leukaemia. N Eng J Med 1979; 301: 439.
104. Shanska A, Kalman A, Crunwald H. A myeloproliferation disorder with eosinophilia associated with a unique translocation (3:5). Br J Haematol 1996; 95: 524.
105. Chan L C, Kwong Y L, Lie AKW, Ching L M. A case of Philadelphia negative M-BCR rearranged eosinophilic leukaemia with trisomy 8, localised by in situ hybridization. Leukaemia 1994; 8: 195.
106. Huang C S, Gomez G A, Kohno S, Sokal J, Sandbery A A. A case of 'hypereosinophilic syndrome' with unusual cytogenetic findings in a chloroma terminating in blastic transformation and CNS leukaemia. Cancer 1979;44: 1284.
107. Ellman L, Hammond D, Atkins L. Eosinophilia, chloromas and chromosome abnormality in a patient with a myeloproliferative syndrome. Cancer 1979; 43: 2410.
108. Weide R, Reider H, Mehraein Y et al. Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. Br J Haematol 1977; 96: 117.
109. Parreira L, Tavares de Castro J, Hibbin J A et al. Chromosomes and cell culture studies in eosinophilic leukaemia. Br J Haematol 1986; 62: 659.
110. Gabbas A G, Li C F. ANLL with eosinophilic differentiation. Am J Haematol 1986; 21: 29.
111. +; 11q). Cancer Genet Cytogenet 1986; 21: 327.
112. Fischkoff S A, Testa J R, Schiffer C A. Acute eosinophilic leukaemia with a (10:11) chromosomal translocation. Leukaemia 1988;2: 394.
113. Darbyshire P J, Shortland D, Swansbury G J, Sadler J, Lawler S D, Chessells J M. A myeloproliferative disease in two infants associated with eosinophilia and chromosome t(1:5) translocation. Br J Haematol 1987; 66: 483.
114. de Vaan G A, van Haelst U J. Hypereosinophilia syndrome or eosinophilic leukaemia. A case report of a one year old infant. Helv Paediatr Acta 1979; 34: 271.
115. Tallgren L G, Wegelius R, Andersson L C, Jansson E. Eosinophilic leukaemia: recovery of mycoplasmaovale from the bone marrow. Acta Med Scand 1974; 195: 87.
116. Faravelli A, Gromo G, Besana C. Fibroplastic endomyocarditis with eosinophilia: presentation of a fatal case and diagnostic considerations on eosinophilic leukaemia. Haematologica (Pavia) 1984; 69: 218.
117. Yam L T, Li C Y, Hecheles T F, Karayama I. Pseudo eosinophilia, eosinophilic endocarditis and eosinophilic leukaemia. Am J Med 1972; 53: 193.
118. Islam N, Karim A K, Rahman K M. Eosinophilic leukaemia. Postgrad Med J 1972; 48: 442.
119. Guitard A M, Horschowski N, Mozziconacci M J et al. Hypereosinophilic syndrome in a child: trisomy 8 and transformation to mixed acute leukaemia. Nouvelle Revue Française D'Hématologie 1993; 35: 555.
120. Egesten A, Hagerstrand I, Kristofferson U, Garwicz S. Hypereosinophilic syndrome in a child mosaic for a congenital triplication of the short arm of chromosome 8. Br J Haematol 1997; 96: 369.
121. Kaneko Y, Kimpara H, Kawai S, Fujimoto T. t(8;21) chromosome translocation in eosinophilic leukaemia. Cancer Genet Cytogenet 1983; 9: 181.
122. Jacobsen R, Temple M J, Sacher R A. Acute myeloblastic leukaemia and t(8;21) translocation. Br J Haematol 1984; 57: 539.
123. Nakamura H, Sadamori N, Tagawa M, Sasagawa I, Itoyama T. Yao E I, Ichimaru M. Inversion of chromosome 16 in bone marrow eosinophils of acute myelomonocytic leukaemia (M4) with eosinophilia. Cancer Genet Cytogenet 1987; 29: 327.
124. Bhambani K, Inone S, Tyrkus M, Gohle N. Acute myelomonocytic leukaemia type M4 with bone marrow eosinophilia and t15;16 (q33;q22). Cancer Genet Cytogenet 1986; 20: 205.
125. Betts D R, Rohatiner A Z, Evans M L, Rassam S M, Lister T A, Gibbons B. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. Leukaemia 1992; 6: 1250.
126. Meeker T C, Hardy D, Willman C, Hogan T, Abrams J. Activation of interleukin 3 gene by chromosomal translocation in acute lymphocytic leukaemia with eosinophilia. Blood 1990; 76: 285.
127. Spitzer G, Garson O M. Lymphoblastic leukaemia with marked eosinophilia. Blood 1973; 42: 377.
128. Troxell M L, Mills G M, Asien R C. The hypereosinophilic syndrome in acute lymphocytic leukaemia. Cancer 1984; 54: 1058.
129. Hogan T F, Koss W, Murgo A J, Amato R S, Fontana J A, van Scoy F L. Acute lymphoblastic leukaemia with chromosomal 5:14 translocation and hypereosinophilia: case report and literature review. J Clin Oncol 1987; 5: 382.
130. Knuutila S, Alitalo R, Ruutu T. Power of the MAC (morphology-antibody-chromosomes) method in distinguishing reactive and clonal cells: report of a patient with acute lymphatic leukaemia, eosinophilia and t(5;14). Genes Chromosomes and Cancer 1993; 8: 219.
131. Kollegger H, Preis P, Maida E, Zielinski C C, Linkesch W, Bcttclhcim P, Aigingcr P. CSF cytology of a patient with conversion of an acute lymphatic leukaemia to an acute eosinophilic leukaemia. Eur Neurol 1986; 25: 320.
132. Matsushima T, Murakami H, Sawamura M et al. Myelodysplastic syndrome with eosinophilia in bone marrow. Br J Haematol 1993;84:636.
133. Oscier D. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? Br J Haematol 1996; 92: 582.
134. Fourth international workshop on chromosomes in leukaemia: 1982 correlation between morphology and karyotype. Cancer Genet Cytogenet 1984; 11: 275.
135. Doorduijn J K, van Lom K, Lowenberg B. Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years. Br J Haematol 1996; 95: 531.
136. Muraka M, Shibuya T, Taniguchi S, Nakashima K, Okamura T. Harada M, Niko Y. Acute eosinophilic leukaemia in a patient with pre-existent myelodysplastic syndrome. Acta Haematol 1991; 86: 42.
137. Muroi K, Miyata T, Saito M, Hatake K, Amemiya Y, Miura Y. Therapy related chronic myelomonocytic leukaemia with bone marrow eosinophilia associated with der (11) t(1:11)(q21:q14). Acta Haematol 1996; 96: 251.
138. Maeda K, van Slyck E J. van Dyke D L. Multiple myeloma terminating in acute eosinophilic leukaemia. Cancer Genet Cytogenet 1985; 16: 81.
139. Shulman L E. Diffuse fasciitis with hypergammaglobulinaemia and eosinophilia: a new syndrome? J Rheumatol 1974; 1 (suppl): 46.
140. Abeles M, Belin D C, Zunier R B. Eosinophilic fasciitis. Arch Intern Med 1979; 139: 586.
141. Lakhanpal S, Ginsburg W W, Michet C J, Doyle J A, Moore S B. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988; 17: 221.
142. Bidula L P, Myer S. Eosinophilic fasciitis associated with haematological disorders: case reports and a review of the literature. Clin Rheumatol Prac 1985; 3: 117.
143. Shulman L E, Hoffman R, Dainiak N et al. Antibody mediated aplastic anaemia and thrombocytopenia in diffuse eosinophilic fasciitis. Arthritis Rheum 1979; 22(suppl): 659.
144. Littlejohn G O, Keystone E C. Eosinophilic fasciitis and aplastic anaemia. J Rheumatol 1980; 7: 730.
145. Hoffman R, Dainiak N, Sibrack L et al. Antibody mediated aplastic anaemia and diffuse fasciitis. N Engl J Med 1979; 300: 718.
146. Hoffman R, Young N, Ershler W B et al. Diffuse fasciitis and aplastic anaemia: a report of 4 cases revealing an unusual association between rheumatologic and haematologic disorders. Medicine (Baltimore) 1982; 61: 73.
147. Mufti G J, Figes A, Hamblin T J, Oscier D G. Copplestone J A. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and auto antibodies. Br J Haematol 1986; 63: 143.
148. Brito-Babapulle F. Patients with eosinophilic fasciitis should have a bone marrow examination to identify myelodysplasia. Br J Dermatol (in press).
149. Spiers A S D, Bain B J, Turner J E. The peripheral blood in chronic granulocytic leukaemia. Scand J Haematol 1977; 18: 25-38.
150. Thomas J R. Eosinophilic leukaemia presenting with erythrocytosis. Blood 1963; 22: 639.
151. Varon D, Wetzle M, Berrebi A. Hypereosinophilic syndrome associated with polycythaemia vera. Arch Intern Med 1986; 146: 1440.
152. Jonte F, Barez A, Solo I et al. Features of chronic myeloid leukaemia at diagnosis. Study of a series of 134 cases. Sangre Bare 1992; 37: 345.
153. Chenk T. Marsh H H. Philadelphia chromosome negative chronic myelogenous leukaemia with prominent eosinophilic component. Am J Clin Pathol 1984; 81: 789.
154. Bennet JM, Catovsky D, Daniel MT et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic. atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994; 87: 746-754.
155. Marinone G, Rossi G, Verzura P. Eosinophilic blast crisis in a case of chronic myeloid leukaemia. Br J Haematol 1983; 55: 251.
156. Shanska A. Kalman A, Grunwald H. A myeloproliferative disorder with eosinophilia associated with a unique translocation (3:5). Br J Haematol 1996; 95: 524.
157. Webb T A, Li C Y, Van L T. Systemic mast cell disease: a clinical and haematopathologic study of 26 cases. Cancer 1982; 49: 927.
158. Tharp M D. The spectrum of mastocytosis. Am J Med Sci 1985; 289: 117.
159. Metcalfe D D. Classification and diagnosis of mastocytosis: current status. Journal of Investigative Dermatology 1991; 96: 25.
160. Horny H P, Kaiserling E, Parwaresch M R, Lennert K. Lymph node findings in generalised mastocytosis. Histopathol 1992; 21: 439.
161. Longley B J, Tyrell L, Lu S et al. Somatic c kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality on a human mast cell neoplasm. Nature Genetics 1996; 12: 312.
162. Fagan K, Hyde S, Harrison P. Translocation (8;13) and T-cell lymphoma. Cancer Genet Cytogenet 1993; 65: 71.
163. Inhorn R C, Aster J C, Roach S A et al. A syndrome of lymphoblastic lymphoma. eosinophilia and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive pathological entity. Blood 1993; 85: 1881.
164. Abbruzzo L V, Jaffe E, Cotelingam J D, Whang-Pen J, Del Duca V, Medeiros L J. T lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 1992; 16: 236.
165. Flaum M A, Schooley R T, Fauci A S, Gralnick H R. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. 1. Haematologic manifestations. Blood 1981; 58: 1012.
166. Schooley R T, Flaum M A, Gralnick H R. Fauci A S. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. Blood 1981; 58: 1021.
167. Weller P F, Bubley G J. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759.
168. Fauci A S, Harley J B, Roberts W C, Ferrano V J, Gralnick H R. Bjornson B H. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Ann Intern Med 1982; 97: 78.
169. Archimbaud E, Guyotat D, Guillaume C, Godard J, Fiere D. HES with multiple organ dysfunction treated by allogeneic bone marrow transplantation. Am J Haematol 1988; 27: 302.
170. Lorenzo E, Meehan K R, Spitzer J, Mazunder A. Allogeneic bone marrow transplantation in a patient with hypereosinophilic syndrome. Am J Haematol 1996; 51: 164.
171. Sigmund D A, Flessa H C. Hypereosinophilic syndrome: successful allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 647.
172. Fukushima T, Kuriama K, Ito H et al. Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome. Br J Haematol 1995; 90: 213.
173. Chusid M J, Dale D C. Eosinophilic leukaemia: remission with vincristine and hydroxyurea. Am J Med 1975; 59: 297.
174. Smit A J, van Essen L H, de Vries E G. Successful long term control of idiopathic hypereosinophilic syndrome with etoposide. Cancer 1991; 67: 2826.
175. Murphy P T, Fennelly D F, Stuart M, O'Donnell J R. Alpha Interferon in a case of hypereosinophilic syndrome. Br J Haematol 1990; 75: 619.
176. Belinski R M, Lawrence W D. Interferon α for the hypereosinophilic syndrome. Ann Intern Med 1990; 113: 716.
177. Canonica G W, Passalacqua G, Pronzato C, Corbetta L, Bagnasco M. Effective long term α interferon treatment for hypereosinophilic syndrome. J Allergy Clin Immunol 1995; 96: 131.
178. + T cells. J Clin Invest 1996; 97: 309.
179. Aldebert D, Laumkhioned B, Desaint C et al. Eosinophils express a functional receptor for interferon a: inhibitory role of interferon α on the release of mediators. Blood 1996; 87: 2354.
180. Suzushima H, Ansou N, Nishimura S et al. Double negative T cells (CD4 CD8) from adult T cell leukaemia patients also have poor expression of the T cell receptor αβ/CD3 complex. Blood 1993; 81: 1032.
181. Palermo A, Moretti S, Difonzo E M, Fattorossi A. Mycosis fungoides with monoclonal gammopathy, hypereosinophilia and hyper IgE. Dermatologica 1984; 169: 194.
182. Oshima Y, Morita M, Hirashima M et al. Characterisation of an eosinophilic leukaemia cell differentiation factor produced by a human T cell leukaemia cell line HIL3. Exp Haematol 1993; 21: 749.
183. Metz J, McGrath K M, Savoia H F, Begley C G, Chetty R. T cell lymphoid aggregates in bone marrow in idiopathic hypereosinophilic syndrome. J Clin Pathol 1993; 46: 955.
184. Brugnoni D, Aiko P, Rossi G et al. A case of hypereosinophilic syndrome associated with the expansion of a CD3- CD4+ T cell population able to secrete large amounts of interleukin 5. Blood 1996; 87: 1416.
185. O'Shea J J, Jaffe E S, Lane H C, MacDermott R P, Fauci A S. Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis: clinical pathologic and immunologic features. Am J Med 1987; 82: 539.
186. Simon H U, Yousefi S, Downmann-Schemer C C et al. Expansion of cytokine producing CD4 . CD8 T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996; 183: 1071.
187. Malbrain M L N G, van den Bergh H, Sachee P. Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality Br J Haematol 1996; 92: 176.
188. Lamkhioued B, Gounni A S, Aldebert D, Delaporte E, Prin L, Capron A, Capron M. Synthesis of type 1 (IFN gamma) and type 2 (IL4, IL5 and IL10) cytokines by human eosinophils. Ann NY Acad Sci 1996; 790: 203.
189. Imashuku S, Hibi S, Fujiwara F, Todo S. Hyperinterleukin 6-anaemia in haemophagocytic lymphohistiocytosis. Br J Haematol 1996; 93: 80.
190. Rohrback M S, Wheatley C L. Slifman N R, Gleich C J. Activation of platelets by eosinophil granule protein. J Exp Med 1990; 172: 1271.
191. Harley J B, Fauci A S, Gralnick H R. Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol 1983; 52: 321.
192. Tominaga A, Takaki S, Koyama N et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 1991; 173: 429.
193. Dent L A, Strath M, Mellor A L, Sanderson C J. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990; 172: 1425.
194. Vaux D L, Lalor P A, Cory S, Johnson G R. In vivo expression of interleukin 5 induces an eosinophilia and expanded Ly-IB lineage populations. Int Immunol 1990; 2: 965.
195. Rosenburg H F, Tenen D G, Ackerman S J. Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci USA 1989; 86: 4460.
196. Young JDE, Peterson CGB, Venge P, Cohn Z A. Mechanism of membrane damage mediated by human eosinophilic cationic protein. Nature 1986; 321: 613.
197. Izumi T, Kishimoto S, Takano T et al. Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation. Biochem J 1995; 305: 829.
198. Seguchi M, Nakajima S. Induction of ICAM-1 expression on the eosinophilic leukaemia cell line-3 (Eol-3) by platelet-activating factor and platelet factor 4. Ann Allergy Asthma Immunol 1995; 74: 255.
199. Wardlaw A J. Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J 1994; 70: 536.
200. Aractingi S, Janin A, Zini J M et al. Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol 1996; 132: 535.
201. Tajima K, Katagiri T. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome. Dig Dis Sci 1996; 41: 282.
202. Olsen E G, Spry C J. Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 1985; 27: 241.
203. Parillo J E, Borerts W L, Henry W L et al. The cardiovascular manifestations of hypereosinophilic syndrome. Am J Med 1979; 67: 572.
204. Moore P M, Harley J B, Fauci A S. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 1985; 102: 109.
205. Waller BF, Grider L, Rohr T M, McLauchlin T, Taliercio C P, Fetters J. Intra cardiac thrombii frequency, location, etiology and complications: a morphologic review. Clin Cardiol 1995; 18: 477 (Part 1).
206. Naito H, Nakatsuka M, Yuki K, Yamada H. Giant left ventricular thrombi in the hypereosinophilic syndrome: report of two cases. J Cardiogr 1986; 16: 475.
207. Hendren W G, Jones E L, Smith M D. Aortic and mitral valve replacement in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 1988; 46: 570.
208. DePace N L, Nestico P F, Morganroth J et al. Dilated cardiomyopathy in the idiopathic hypereosinophilic syndrome. Am J Cardiol 1983; 52: 1359.
209. Lupo I, Daniele O, Raimondo D, Rodolico V, Camarda R M. Peripheral neuropathy in the hypereosinophilic syndrome: a case report. Eur Neurol 1989; 29: 269.
210. Roche S, Cross S, Kaufman B. Intracranial haemorrhages occurring in the idiopathic hypereosinophilic syndrome. J Neurol Neurosurg Psychiatr 1990; 53: 440 (letter).
211. Weaver D F, Hefferman L P, Purdy R A, Ing V W. Eosinophil-induced neurotoxicity: axonal neuropathy, cerebral infarction and dementia. Neurology 1988; 38: 144.
212. Prick JJW, Gabreëls-Festen A A W M, Korten J J, van der Wiel T W M. Neurological manifestations of the hypereosinophilic syndrome (HES). Clin Neurol Neurosurg 1988; 90: 269.
213. Weingarten J S, O'Sheal S F, Margolis W S. Eosinophilic meningitis and the hypereosinophilic syndrome. Case report and review of the literature. Am J Med 1985; 78: 674.
214. van den Hoogenband H M. Skin lesions as the first manifestation of the hypereosinophilic syndrome. Clin Exp Dermatol 1982; 7: 267.
215. Nir M A, Westfried M. Hypereosinophilic dermatitis. A distinct manifestation of the hypereosinophilic syndrome with response to Dapsone. Dermatologica 1981; 162: 444.
216. Leiferman K M, O'Duffy J D, Perry H O, Greipp O R, Gruliani F R, Gleich G J. Recurrent incapacitating mucosal ulcerations: a prodrome of the hypereosinophilic syndrome. JAMA 1982; 247: 1018.
217. Brugger F, Treuner J, Undeutsch W. Hypereosinophiliesyndrom (eosinophiles leukamoid) mit dermaler exanthematischer vestikulo-bulloser Manifestation. X Hautkr 1980; 55: 855.
218. Fitzpatrick J E, Johnson C, Simon P, Owenby J. Cutaneous microthrombi: a histologic clue to the diagnosis of hypereosinophilic syndrome. Am J Dermatopathol 1987; 9: 419.
219. Cordier J F, Faure M, Hermier C, Brune J. Pleural effusions in an overlap syndrome of idiopathic hypereosinophilic syndrome and erythema elevatum diutinem. Eur Respir J 1990; 3: 115.
220. Epstein D M, Taortaina V, Gefter W B, Miller W T. The hypereosinophilic syndrome. Radiology 1981; 140: 59.
221. Chaine G, Davies J, Kohner E M, Hawarth S, Spry C J. Ophthalmologic abnormalities in the hypereosinophilic syndrome. Ophthalmology 1982; 89: 1348.
222. Binaghi M. Perrenoud F, Dhermy P, Coscas G. Syndrome hypereosinophilique avec atteninte oculaire. J Fr Opthalmol 1985; 8: 309.
223. Farcet J P, Binaghi M, Kuentz M et al. A hypereosinophilic syndrome with retinal arteritis and tuberculosis. Arch Intern Med 1982; 142: 625.
224. Hillerdal G, Marjanovic B, Aberg H. Rheumatoid arthritis, immune complex disease and hypereosinophilic syndrome. Report on a case. Acta Med Scand 1979; 206: 429.
225. Brogadir S P, Goldwein M I, Schumacher H R. A hypereosinophilic syndrome mimicking rheumatoid arthritis. Am J Med 1980; 69: 799.
226. Martin-Santos J M, Mulero J, Andreu J L, de Villa L F. Bernaldo-de Quiros L, Noguera E. Arthritis in idiopathic hypereosinophilic syndrome. Arthr Rheum 1988; 31: 120.
227. Layzer R B, Shearn M A, Satya-Murti S. Eosinophilic polymyositis. Ann Neurol 1976; 1: 65.
228. Takekawa M, Imai K, Adachi M et al. Hypereosinophilic syndrome accompanied with necrosis of finger tips. Intern Med 1992; 31: 1262.
229. Spry C J, Davies J, Tai P C. Olsen E G. Oakley C M. Goodwin J F. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 1983; 52: 1.
230. Shah A M, Joglekar M. Eosinophilie colitis as a complication of the hypereosinophilic syndrome. Postgrad Med J 1987; 63: 485.
231. Falade A G, Darbyshire P J, Raafat F, Booth I W. Hypereosinophilic syndrome in childhood appearing as inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12: 276.
232. Scheurlen M, Mork H, Weber P. Hypereosinophilic syndrome resembling chronic inflammatory bowel disease with primary sclerosing cholangitis. J Clin Gastroenterol 1992; 14: 59.
233. Elouaer B L, Zafrani E S, Farcet J P. Saint Marc G M, Mathieu D, Dhumeaux D. Hepatic vein obstruction in idiopathic hypereosinophilic syndrome. Arch Intern Med 1985; 145: 751.
234. Vargas C A, Maldonado O, Botero R C et al. Budd-Chiari syndrome associated with the hypereosinophilic syndrome. Am J Gastroenterol 1993; 88: 1802 (letter).